The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database study
{{output}}
Background: Treatment strategy for relapsing multiple sclerosis (RMS) is increasingly shifting toward first-line use of high-efficacy DMT (H-DMT). However, differences in DMT efficacy appear to decline with increasing age, and th... ...
